Table 4

Characteristics of patients with isolated traumatic brain injury aged ≥60 years and meeting the Brain Trauma Foundation guidelines for ICP monitoring, by ICP status (n=240)

ICP, n=43No ICP, n=197P value*
Age in years, mean (SD)71.2 (7.4)75.6 (9.1)0.004
Age categories, n (%)0.01
 60–8138 (88.4)137 (69.5)
 >815 (11.6)60 (30.5)
 Sex, n (%)0.19
 Female15 (34.9)90 (45.7)
 Male28 (65.1)107 (54.3)
 Race, n (%)0.17
 White27 (62.8)151 (76.7)
 Black7 (16.3)19 (9.6)
 Other9 (20.9)27 (13.7)
Comorbidities, n (%)
 Neurological13 (37.1)66 (36.3)0.92
 Cardiac disease26 (74.3)147 (80.8)0.38
 Respiratory disease5 (14.3)40 (21.9)0.30
 Kidney disease6 (17.1)22 (12.1)0.41
 Liver disease2 (5.7)10 (5.5)0.96
 Anticoagulants at home, n (%)6 (13.9)42 (21.3)0.27
 Warfarin4 (9.3)25 (12.7)0.54
 Direct oral anticoagulants2 (7.1)15 (10.0)0.64
 Antiplatelet use at home, n (%)10 (23.3)68 (34.5)0.15
Cause of injury, n (%)0.05
 Motor vehicle collision10 (23.3)21 (10.9)
 Fall30 (69.8)164 (84.9)
 Assault2 (4.7)2 (1.0)
 Other1 (2.3)6 (3.1)
Head AIS score, n (%)0.73
 21 (2.3)9 (4.6)
 36 (13.9)36 (18.3)
 49 (20.9)35 (17.8)
 527 (62.8)113 (57.4)
 604 (2.0)
GCS score†, n (%)0.12
 317 (39.5)108 (54.8)
 45 (11.6)11 (5.6)
 52 (4.7)7 (3.6)
 63 (6.9)28 (14.2)
 79 (20.9)21 (10.7)
 87 (16.3)22 (11.2)
Initial CT results, n (%)
 Subdural hematoma36 (83.7)160 (81.2)0.70
 Epidural hematoma4 (9.3)12 (6.1)0.44
 Intraventricular hemorrhage10 (23.3)33 (16.8)0.31
 Subarachnoid hemorrhage30 (69.8)103 (52.3)0.04
 Intraparenchymal hemorrhage18 (41.9)44 (22.3)0.01
 Cerebral edema7 (16.3)29 (14.7)0.79
 Skull fracture23 (53.5)39 (19.8)<0.001
 CT worsening (any), n (%)27 (62.8)80 (40.6)0.01
Pupil reactivity, n (%)0.37
 Both24 (55.8)105 (53.3)
 One6 (13.9)16 (8.12)
 Neither13 (30.2)76 (38.6)
 Neurosurgical intervention, n (%)23 (53.5)50 (25.4)<0.001
 Craniotomy15 (34.9)37 (18.8)0.02
 Craniectomy8 (18.6)15 (7.6)0.03
 Tracheostomy, n (%)12 (27.9)11 (5.6)<0.001
 PEG tube/gastrostomy, n (%)14 (32.6)21 (10.7)<0.001
 Platelet transfusion, n (%)7 (16.3)36 (18.3)17.9
Reversal agents administered, n (%)
 Vitamin K5 (23.8)16 (8.1)0.46
 Fresh frozen plasma7 (16.3)34 (17.3)0.88
 Three-factor prothrombin complex concentrate43 (100)196 (99.5)0.64
 Length of hospital stay in days, median (IQR)12 (20)5 (8)<0.001
 Length of ICU stay in days, median (IQR)10.5 (10)4 (7)<0.001
 Ventilator days, median (IQR)6.5 (10)3 (6)<0.001
 Palliative interventions, n (%)20 (47.6)107 (54.6)0.41
 Do not attempt resuscitation, n (%)14 (32.6)65 (33.0)0.96
  Days from admission, median (IQR)5 (3–9)1 (1–4)0.002
 Palliative care consult, n (%)7 (16.3)38 (19.3)0.65
  Days from admission, median (IQR)6 (2–11)2 (1–5)0.17
 Discontinuation of life-sustaining measures, n (%)13 (30.2)66 (33.5)0.68
  Days from admission, median (IQR)5 (5–14)2 (1–5)0.002
 Hospice care, n (%)023 (11.7)0.02
  Days from admission, median (IQR)n/a2 (2–6)n/a
 Death at discharge, n (%)23 (53.5)118 (59.9)0.44
 Change in residence, n (%)0.97
 More care required/deceased39 (90.7)179 (90.9)
  • *P value comparing across age categories from Student’s t-test, Wilcoxon rank-sum, or χ2 goodness of fit.

  • †Best postresuscitation GCS score.

  • AIS, Abbreviated Injury Scale; GCS, Glasgow Coma Scale; ICP, intracranial pressure; ICU, intensive care unit; n/a, not available; PEG, percutaneous endoscopic gastrostomy.